The main aim of our study was to evaluate anti-tumor effectiveness of combined radio-gene therapy with the plasmid encoding therapeutic gene Il-12 under the control of the inducible p21 promoter in a mouse mammary adenocarcinoma tumor model. The gene discussed is CDKN1A; the disease is neoplasm.